Companies - Fagron

Price

 
Price
€ 12,22
Change
€ 0,03
Change %
0,24%
Open
€ 12,26
High
€ 12,34
Low
€ 12,15
Volume
91.735

Profile

 
Profile
Fagron is specialized in the development, sale and distribution of personal care products and services intended for professionals in the health sector (doctors, pharmacists, dentists, hospitals, nursing homes, etc.).
Industry
Pharmaceutical
Description
Companies in the pharmaceutical industry develop and sell drugs. In addition, licenses on newly developed drugs are sold to other companies. Medications are strictly supervised by different supervisors. This, and the complex process of developing new drugs results in the long development time before a product makes it to the market. Companies that develop new drugs benefit from long-term protection of their products through patents. This allows them to make money on a new drug.

Key figures (2016)

 
The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings
-32,070
Price to Earnings (3 years)
-9,919
Price to Earnings (5 years)
-17,572
Price to earnings growth
-
Price/cashflow
13,478
Price/net cashflow
3,052
Price/book value
4,313
Price to sales
1,551

Ratios for dividend

Dividend yield
-
Pay out
-

Valuation ratios

Market value/PE
4,313
Market value/turnover
1,551
Enterprise value/turnover
1,536

Return ratios

Return on private equity
-13,45%
Return on total equity
-2,41%
Profit margin
-4,84%

Risk ratios

Solvability
0,179
Solvability
1,218
Current ratio
1,016
Debt to Equity
4,578

Value invest ratios

Grahams Number
€ -5,61
Grahams Value
€ -17,83
Grahams Product
-138,313
Grahams Product (3 years)
-42,778

2016

 

Profit and loss

Net profit (x 1 mln)
€ -20,56
Turnover (x 1 mln)
€ 425,05
Cashflow(x 1 mln)
€ 48,92
Net cashflow(x 1 mln)
€ 216,01

Balance

Private equity (x 1 mln)
€ 152,88
Foreign equity (x 1 mln)
€ 699,96
Current assets (x 1 mln)
€ 397,13
Current liabilities (x 1 mln)
€ 390,84
Working capital (x 1 mln)
€ 6,29
Balance total (x 1 mln)
€ 852,84

Share

Outstanding shares (x 1 mln)
53,957
Price year-end
€ 9,71
Dividend per share
-
Earnings per share
€ -0,38
Cashflow per share
€ 0,91
Net cashflow per share
€ 4,00
Book value per share
€ 2,83
Stockmarket value (x 1 mln)
€ 524,08

History

 
Year
2016
2015
2014
2013
2012
Net profit (x 1 mln)
€ -20,56
€ -195,10
€ 16,23
€ -32,10
€ 43,91
Turnover (x 1 mln)
€ 425,05
€ 481,66
€ 450,41
€ 387,18
€ 547,60
Price year-end
€ 9,71
€ 6,81
€ 6,81
€ 6,81
€ 6,81
Year high
€ 10,59
€ 6,81
€ 6,81
€ 6,81
€ 6,81
Year low
€ 3,79
€ 6,81
€ 6,81
€ 6,81
€ 6,81
Outstanding shares (x 1 mln)
53,957
31,304
31,431
30,647
30,520
Price to Earnings
-25,490
-1,093
13,188
-6,502
4,733
Earnings per share
€ -0,38
€ -6,23
€ 0,52
€ -1,05
€ 1,44
Dividends
-
-
€ 1,00
€ 0,72
€ 0,50
Dividend yield
-
-
14,68%
10,57%
7,34%
Pay out
-
-
193,66%
-68,74%
34,75%
Private equity (x 1 mln)
€ 152,88
€ -64,77
€ 156,95
€ 155,17
€ 245,38
PE per share
€ 2,83
€ -2,07
€ 4,99
€ 5,06
€ 8,04
Balance total (x 1 mln)
€ 852,84
€ 689,38
€ 973,75
€ 804,69
€ 748,89
Stockmarket value (x 1 mln)
€ 524,08
€ 213,18
€ 214,05
€ 208,71
€ 207,84

Company analysis

 

Analysis of profit indicators

Average profit per share (5 years)
€ -0,95
Standard deviation average profit
€ 2,82 (-295,21%)
Average annual growth rate
-66,58%
Compound annual growth percentage
16,45%